Inventiva: Status of voting rights and shares as of May 13, 2024

The biopharmaceutical company Inventiva has communicated the figures relating to the voting rights and shares making up its share capital as of May 13, 2024. In accordance with article R. 22-10-23 of the Commercial Code, this information concerns the regulated market of 'Euronext Paris.

The company's share capital consists of 52,477,188 outstanding shares. The number of gross voting rights reaches 65,493,081, while the number of net voting rights amounts to 65,381,630. This data is calculated by taking into account shares with and without voting rights.

This publication aims to ensure total transparency towards investors and stakeholders, thus consolidating the company's position on the financial markets.